Behandeling van astma tijdens de zwangerschap

Treatment of asthma during pregnancy leads to discussion concerning medication and complications of pregnancy.

Insecurity about possible teratogenity leads in the first trimester in 40% of pregnant women to reduction or cessation of asthma medication.

This results, in pregnant women with moderate to severe asthma, in an increased consumption of rescue medication and number of exacerbations, and reduced asthma control.

Astma-exacerbations are significantly correlated with low birthweight.

Of the majority of asthma medications, consumption during pregnancy has not been shown to cause harmfull effects on the foetus.

Adequate therapy for maintenance and exacerbations are essential, noting that the treatment in essence should not differ between pregnant and nonpregnant asthmatic women.

A preconceptional consultation by a pulmonary physician and gynaecologist could improve care for pregnant women with asthma.